20 June 2019
New Approaches in Medicinal Chemistry
Organised by:
SCI's Young Chemists' Panel
Cambridge, UK
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
This one-day symposium is aimed at exploring the latest approaches in drug discovery and will review the hottest topics towards discovering the drugs of tomorrow. Bringing together a wide range of industrial speakers, the day will cover a broad range of approaches and new targets within drug discovery.
Topics will cover both small molecule drug discovery as well as looking at those approaches to larger molecules such as antibody drug conjugates and bicyclic peptides. The meeting will cover a range of topics, from exploring the ways artificial intelligence and computational chemistry can impact drug discovery, to new targets for research within deubiquintinating enzymes and immune-oncology.
Attendees
The meeting will be ideal for both experienced and more junior medicinal chemists in the drug discovery and medicinal chemistry fields. With a wide range of talks covering the pharmaceutical and biotechnology industry, both industrial and academic scientists will be interested in the event.Programme
| 09.00 | Registration | |
| 09.40 | Introduction and welcome | |
| 09.50 | The challenges of prosecuting RNA-modifying enzymes as drug discovery targets Dr. David Hardick, Storm Therapeutics |
|
| 10.25 |
Driven by Data: A Case Study of AI applied to ALS drug discovery Dr. Rebecca Paul, BenevolentAI |
|
| 11.00 | Refreshments | |
| 11.30 |
Combining reaction-based enumeration, free energy perturbation and active learning in hit-to-lead campaigns: the case of CDK2 Dr. Davide Branduardi, Schrödinger |
|
| 12.05 |
Bringing it all together: Structure based PROTAC design Mr. Will Farnaby, Biological Chemistry and Drug Discovery, University of Dundee |
|
| 12.40 | Lunch | |
| 13.40 |
Discovery of Adenosine A2a Antagonist HTL1071/AZD4635 using Structure-Based Drug Design Dr. Miles Congreve, Heptares |
|
| 14.15 |
Next Generation Drug Discovery: Encoded Library Technology in Nanospheres Dr. James Dale, Nanna Therapeutics |
|
| 14.50 | Refreshments | |
| 15.20 |
Holmes Adventures in the Hypercube Dr. Mike Bodkin, Evotec |
|
| 15.55 |
Bicycle Toxin Conjugates: A novel approach in targeted cancer therapy Dr. Gemma Mudd, Bicycle Therapeutics |
|
| 16.30 | Networking and refreshments |
Venue and Contact
SCI
Babraham Hall
Cambridge
CB22 3AT
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org
Fees
Early bird fees before Thursday 9 May 2019
| £90 | SCI Member | |
| £30 | SCI Student Member | |
| £60 | SCI Subsidised Member | |
| £120 | Non-Member |
Standard fees after Thursday 9 May 2019
| £125 | SCI Member | |
| £40 | SCI Student Member | |
| £80 | SCI Subsidised Member | |
| £170 | Non-Member |
SCI Platinum Corporate Members receive 25% off the above rate
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
Booking terms and conditionsCPD Info
SCI Members attending this meeting are able to claim CPD points.
Exhibitors
Sponsors
Additional Information
Organising Committee
- Ed Balmond, SCI/ BenevolentAI, UK
- Peter Blencowe, SCI/ Cancer Research UK
- Christopher Brown, SCI/ CRL
Call for posters
If you would like to present a poster, please send an abstract of maximum one A4 page or 300 words including schemes and references and indicating title and authors.
Please send this to conferences@soci.org by Friday 7 June 2019 with the subject line " new approaches in medicinal chemistry III" - poster submission".
